Related Experiment Video
Updated: May 21, 2026

Knockdown of FAM83A to Verify Its Role in Cervical Cancer Cell Growth and Cisplatin Sensitivity
Published on: February 9, 2024
Downregulation of SWI/SNF chromatin remodeling factor subunits modulates cisplatin cytotoxicity
Anbarasi Kothandapani1, Kathirvel Gopalakrishnan, Bhaskar Kahali
1Department of Biochemistry and Cancer Biology, University of Toledo-Health Science Campus, Toledo, OH 43614, USA.
Abstract:
Chromatin remodeling complex SWI/SNF plays important roles in many cellular processes including transcription, proliferation, differentiation and DNA repair. In this report, we investigated the role of SWI/SNF catalytic subunits Brg1 and Brm in the cellular response to cisplatin in lung cancer and head/neck cancer cells. Stable knockdown of Brg1 and Brm enhanced cellular sensitivity to cisplatin. Repair kinetics of cisplatin DNA adducts revealed that downregulation of Brg1 and Brm impeded the repair of both intrastrand adducts and interstrand crosslinks (ICLs). Cisplatin ICL-induced DNA double strand break repair was also decreased in Brg1 and Brm depleted cells. Altered checkpoint activation with enhanced apoptosis as well as impaired chromatin relaxation was observed in Brg1 and Brm deficient cells. Downregulation of Brg1 and Brm did not affect the recruitment of DNA damage recognition factor XPC to cisplatin DNA lesions, but affected ERCC1 recruitment, which is involved in the later stages of DNA repair. Based on these results, we propose that SWI/SNF chromatin remodeling complex modulates cisplatin cytotoxicity by facilitating efficient repair of the cisplatin DNA lesions.
Insights
The SWI/SNF chromatin remodeling complex, involving Brg1 and Brm, enhances cancer cell sensitivity to cisplatin by aiding DNA repair. Its depletion impairs the repair of cisplatin DNA adducts and double-strand breaks.
Area of Science:
- Molecular Biology
- Cancer Research
- Chromatin Dynamics
Background:
- The SWI/SNF chromatin remodeling complex is crucial for various cellular processes, including DNA repair.
- Cisplatin is a widely used chemotherapy agent that induces DNA damage.
Purpose of the Study:
- To investigate the role of SWI/SNF subunits Brg1 and Brm in the cellular response to cisplatin in lung and head/neck cancer cells.
- To elucidate the mechanism by which SWI/SNF influences cisplatin-induced DNA damage repair.
Main Methods:
- Stable knockdown of Brg1 and Brm in cancer cell lines.
- Assessment of cellular sensitivity to cisplatin.
- Analysis of DNA adduct repair kinetics and DNA double-strand break repair.
- Evaluation of chromatin relaxation, checkpoint activation, and apoptosis.
- Investigation of DNA damage recognition factor recruitment (XPC and ERCC1).
Main Results:
- Knockdown of Brg1 and Brm increased cisplatin sensitivity.
- Downregulation of Brg1 and Brm impaired the repair of cisplatin DNA adducts (intrastrand and interstrand crosslinks) and ICL-induced double-strand breaks.
- Brg1 and Brm deficiency led to altered checkpoint activation, enhanced apoptosis, and impaired chromatin relaxation.
- While XPC recruitment was unaffected, ERCC1 recruitment was impaired in Brg1 and Brm depleted cells.
Conclusions:
- The SWI/SNF chromatin remodeling complex, through Brg1 and Brm, plays a significant role in modulating cisplatin cytotoxicity.
- SWI/SNF facilitates efficient repair of cisplatin-induced DNA lesions, impacting therapeutic outcomes.
- Targeting SWI/SNF may represent a strategy to enhance the efficacy of cisplatin chemotherapy.
Related Concept Videos
Chromatin Modification in iPS Cells
Compact chromatin makes reprogramming difficult. Enzymes, such as histone demethylases and acetyltransferases, are often added during reprogramming to loosen the chromatin, making the DNA more accessible to transcription factors. Molecules that inhibit histone...
Abnormal Proliferation
Nucleosome Remodeling
Nucleosome remodeling complex
Eukaryotic cells have specialized enzymes called ATP-dependent nucleosome remodeling enzymes. These enzymes...
